Chronic kidney failure and end-stage renal disease (ESRD) are increasing globally, but home hemodialysis offers a critical means of improving patient quality of life and reducing national healthcare costs. This study investigates the performance of a portable hemodialysis (HD) device named XKIDNEY. The efficacy and safety of the device were determined with focus on solute clearance, fluid balancing accuracy, and blood cell integrity in an ex-vivo test environment. A comparison of the performance of XKIDNEY and a conventional HD unit showed that XKIDNEY had superior balancing accuracy without any technical malfunction. In addition, low molecular weight solutes, such as urea and creatinine, were effectively removed. These findings demonstrate that XKIDNEY enhances treatment portability without compromising performance and indicate XKIDNEY is a feasible home hemodialysis option.